What SMT Research and Development does

SMT Research and Development is an Israel-based medical device company, founded in 2004 and headquartered in Herzliya, that develops and commercializes procedural accessories used during Transcatheter Aortic Valve Implantation (TAVI) and other heart procedures. The company operates in the structural heart and interventional cardiology accessories category, supplying tools that interventional cardiologists and cardiac surgeons use adjunctively during transcatheter valve procedures. Its product surface is oriented around procedural enablement rather than implantable devices themselves, positioning SMT as a complementary supplier in the TAVI workflow alongside valve manufacturers and imaging/cath lab capital equipment vendors.

The company's commercial model appears to be B2B sales of single-use or limited-use medical accessories to hospitals and cardiac surgery centers, though the provided data does not disclose pricing, contract structures, distributor relationships, or specific product SKUs. In April 2011, SMT secured a $10.5 million financing round led by OrbiMed, a healthcare-specialist investor, which provided capital for product development and commercialization. The company's website (smtmed.com) is referenced as the corporate web property, although one indexed source shows the domain listed for sale on the Atom.com premium domain marketplace, introducing ambiguity about the company's current operating status.

The available data is thin on operational details: no headcount, management team, regulatory filings, patent portfolio, named customers, geographic footprint, or revenue figures are disclosed. This limits the ability to assess SMT's current scale, market share, or competitive position within the global TAVI accessories market, which has grown substantially since 2011 alongside the broader adoption of transcatheter valve therapies.

Name

SMT Research and Development

Website

https://smtmed.com

Company type

Private

Founded year

2004

Short description

SMT Research and Development is an Israel-based medical device company, founded in 2004 and based in Herzliya, that develops and commercializes procedural accessories used during TAVI and other heart procedures for interventional cardiology and cardiac surgery customers.

Ownership category

akta.pro rank

Headquarters

HQ city

Herzliya

HQ country

Israel

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales

Core offering

SMT Research and Development is a medical device company that develops and commercializes procedural accessories used during TAVI (Transcatheter Aortic Valve Implantation) and other heart procedures. Its offering consists of single-use accessory devices designed to support interventional cardiologists and cardiac surgeons performing transcatheter structural heart interventions. The company is based in Herzliya, Israel and was founded in 2004.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights1 record

Broad incumbents

• Boston Scientific: Active in structural heart through its WATCHMAN franchise and a portfolio of vascular access and closure accessories used in TAVI procedures. Comparable as a broad incumbent with overlapping TAVI accessory exposure.
• Medtronic: Operates the CoreValve/Evolut TAVI platform and supplies associated procedural accessories across structural heart. Comparable as a broad incumbent that controls both valves and the accessory ecosystem around them.
• Abbott: Markets the Portico TAVI system and adjacent structural heart devices including vascular closure and access products. Comparable as a broad incumbent operating across the structural heart procedure stack.

Emerging players

• JenaValve Technology: Developer of transcatheter aortic and regurgitation valve systems with associated delivery accessories. Comparable as an emerging structural heart player addressing overlapping TAVI/TAVR clinical indications.
• CroiValve: Early-stage developer of a transcatheter tricuspid repair technology delivered through dedicated procedural accessories. Comparable as an emerging structural heart company whose commercial success depends on the same interventional cardiology channels SMT serves.
• Meril Life Sciences: India-based developer of the Myval transcatheter heart valve system and related accessories. Comparable as an emerging TAVI player outside the dominant US/EU incumbents with a similar product-and-accessory focus.
• 4C Medical Technologies: Emerging developer of transcatheter mitral and tricuspid valve technologies with proprietary delivery accessory platforms. Comparable as an emerging structural heart device company investing in proprietary procedural accessory technology.

Regional players

• Venus Medtech: Chinese TAVI developer with the VenusA and VenusP-Valve systems and a growing accessory portfolio. Comparable as a regional TAVI systems-and-accessories competitor, primarily serving Asia.

Direct peers

• Edwards Lifesciences: Global leader in TAVI/TAVR through its Sapien platform and also markets the Sentinel cerebral protection system, a TAVI procedural accessory. Directly comparable as a TAVI accessory developer and the dominant structural heart incumbent.
• Teleflex: Markets the Manta vascular closure device, a leading dedicated accessory for large-bore TAVI access closure. Highly comparable as a focused supplier of procedural accessories in the same cath lab workflow.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SMT Research and Development